Trial Profile
A Randomized, Double-Blind, Placebo-Controlled Study Evaluating Asimadoline on the Duration of POI in Subjects Undergoing Laparoscopic/Hand-Assisted Lap Segmental Colonic Resection Secondary to Colon Cancer, Polypectomy or Diverticulitis
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 03 May 2014
Price :
$35
*
At a glance
- Drugs Asimadoline (Primary)
- Indications Postoperative ileus
- Focus Therapeutic Use
- Sponsors Tioga Pharmaceuticals
- 03 May 2014 New trial record